CHEK2
mutations in pediatric brain tumors
Neurooncol Adv
.
2023 Apr 14;5(1):vdad038.
doi: 10.1093/noajnl/vdad038.
eCollection 2023 Jan-Dec.
Authors
Dana Tlais
1
,
Maria Isabel Barros Guinle
2
,
Joshua Riley Wheeler
3
,
Laura M Prolo
4
,
Hannes Vogel
3
,
Sonia Partap
1
Affiliations
1
Department of Neurology, Stanford University, Palo Alto, California, USA.
2
Stanford University School of Medicine, Palo Alto, California, USA.
3
Department of Pathology and Neuropathology, Stanford University, Palo Alto, California, USA.
4
Department of Neurosurgery, Stanford University, Palo Alto, California, USA.
PMID:
37207118
PMCID:
PMC10191190
DOI:
10.1093/noajnl/vdad038
No abstract available
Keywords:
CHEK2 mutation; CNS tumors; molecular profiling; pediatrics.